SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001171843-20-005655
Filing Date
2020-08-06
Accepted
2020-08-06 16:05:39
Documents
3
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A f10qa_073120.htm 10-Q/A 31542
2 EXHIBIT 31.3 exh_313.htm EX-31.3 3876
3 EXHIBIT 31.4 exh_314.htm EX-31.4 3803
  Complete submission text file 0001171843-20-005655.txt   40404
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Filer) CIK: 0000898437 (see all company filings)

IRS No.: 043145961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-14027 | Film No.: 201081549
SIC: 3841 Surgical & Medical Instruments & Apparatus